Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen:
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | German |
Veröffentlicht: |
München u.a.
Zuckschwerdt
1987
|
Schlagworte: | |
Beschreibung: | Engl. Ausg. u.d.T.: Illiger, Hans J.: Drug interactions in the therapy of malignant diseases |
Beschreibung: | XXX, 140 S. |
ISBN: | 3886032515 3886032396 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV000736217 | ||
003 | DE-604 | ||
005 | 20070306 | ||
007 | t | ||
008 | 880425s1987 |||| 00||| ger d | ||
020 | |a 3886032515 |9 3-88603-251-5 | ||
020 | |a 3886032396 |9 3-88603-239-6 | ||
035 | |a (OCoLC)74932932 | ||
035 | |a (DE-599)BVBBV000736217 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a ger | |
049 | |a DE-12 |a DE-29 |a DE-188 | ||
084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
100 | 1 | |a Illiger, Hans J. |e Verfasser |4 aut | |
240 | 1 | 0 | |a Drug interactions in the therapy of malignant diseases |
245 | 1 | 0 | |a Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |c H. J. Illiger ; K. Herdrich |
264 | 1 | |a München u.a. |b Zuckschwerdt |c 1987 | |
300 | |a XXX, 140 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Engl. Ausg. u.d.T.: Illiger, Hans J.: Drug interactions in the therapy of malignant diseases | ||
650 | 4 | |a Zytostatika | |
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Chemotherapeutikum |0 (DE-588)4009895-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakokinetik |0 (DE-588)4115557-9 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | 2 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 1 | 1 | |a Chemotherapeutikum |0 (DE-588)4009895-3 |D s |
689 | 1 | 2 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
689 | 1 | |8 1\p |5 DE-604 | |
689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 2 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
689 | 2 | 2 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
689 | 2 | |8 2\p |5 DE-604 | |
689 | 3 | 0 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
689 | 3 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 3 | 2 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 3 | |8 3\p |5 DE-604 | |
689 | 4 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 4 | 1 | |a Arzneimittelwechselwirkung |0 (DE-588)4003147-0 |D s |
689 | 4 | |8 4\p |5 DE-604 | |
700 | 1 | |a Herdrich, Klaus |e Verfasser |4 aut | |
999 | |a oai:aleph.bib-bvb.de:BVB01-000460910 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804115187978993664 |
---|---|
any_adam_object | |
author | Illiger, Hans J. Herdrich, Klaus |
author_facet | Illiger, Hans J. Herdrich, Klaus |
author_role | aut aut |
author_sort | Illiger, Hans J. |
author_variant | h j i hj hji k h kh |
building | Verbundindex |
bvnumber | BV000736217 |
classification_rvk | XH 3200 |
ctrlnum | (OCoLC)74932932 (DE-599)BVBBV000736217 |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02898nam a2200697 c 4500</leader><controlfield tag="001">BV000736217</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070306 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">880425s1987 |||| 00||| ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3886032515</subfield><subfield code="9">3-88603-251-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3886032396</subfield><subfield code="9">3-88603-239-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)74932932</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000736217</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Illiger, Hans J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="240" ind1="1" ind2="0"><subfield code="a">Drug interactions in the therapy of malignant diseases</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen</subfield><subfield code="c">H. J. Illiger ; K. Herdrich</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">München u.a.</subfield><subfield code="b">Zuckschwerdt</subfield><subfield code="c">1987</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXX, 140 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Engl. Ausg. u.d.T.: Illiger, Hans J.: Drug interactions in the therapy of malignant diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Zytostatika</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapeutikum</subfield><subfield code="0">(DE-588)4009895-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapeutikum</subfield><subfield code="0">(DE-588)4009895-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Arzneimittelwechselwirkung</subfield><subfield code="0">(DE-588)4003147-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Herdrich, Klaus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000460910</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
id | DE-604.BV000736217 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T15:18:38Z |
institution | BVB |
isbn | 3886032515 3886032396 |
language | German |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000460910 |
oclc_num | 74932932 |
open_access_boolean | |
owner | DE-12 DE-29 DE-188 |
owner_facet | DE-12 DE-29 DE-188 |
physical | XXX, 140 S. |
publishDate | 1987 |
publishDateSearch | 1987 |
publishDateSort | 1987 |
publisher | Zuckschwerdt |
record_format | marc |
spelling | Illiger, Hans J. Verfasser aut Drug interactions in the therapy of malignant diseases Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich München u.a. Zuckschwerdt 1987 XXX, 140 S. txt rdacontent n rdamedia nc rdacarrier Engl. Ausg. u.d.T.: Illiger, Hans J.: Drug interactions in the therapy of malignant diseases Zytostatika Cytostatikum (DE-588)4068347-3 gnd rswk-swf Chemotherapie (DE-588)4127083-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Chemotherapeutikum (DE-588)4009895-3 gnd rswk-swf Arzneimittelwechselwirkung (DE-588)4003147-0 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Therapie (DE-588)4059798-2 s Arzneimittelwechselwirkung (DE-588)4003147-0 s DE-604 Chemotherapeutikum (DE-588)4009895-3 s 1\p DE-604 Chemotherapie (DE-588)4127083-6 s Pharmakokinetik (DE-588)4115557-9 s 2\p DE-604 Pharmakotherapie (DE-588)4076066-2 s 3\p DE-604 Cytostatikum (DE-588)4068347-3 s 4\p DE-604 Herdrich, Klaus Verfasser aut 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Illiger, Hans J. Herdrich, Klaus Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen Zytostatika Cytostatikum (DE-588)4068347-3 gnd Chemotherapie (DE-588)4127083-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Chemotherapeutikum (DE-588)4009895-3 gnd Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Therapie (DE-588)4059798-2 gnd Pharmakokinetik (DE-588)4115557-9 gnd |
subject_GND | (DE-588)4068347-3 (DE-588)4127083-6 (DE-588)4073781-0 (DE-588)4076066-2 (DE-588)4009895-3 (DE-588)4003147-0 (DE-588)4059798-2 (DE-588)4115557-9 |
title | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
title_alt | Drug interactions in the therapy of malignant diseases |
title_auth | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
title_exact_search | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
title_full | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
title_fullStr | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
title_full_unstemmed | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen H. J. Illiger ; K. Herdrich |
title_short | Arzneimittelinteraktionen bei der Therapie maligner Erkrankungen |
title_sort | arzneimittelinteraktionen bei der therapie maligner erkrankungen |
topic | Zytostatika Cytostatikum (DE-588)4068347-3 gnd Chemotherapie (DE-588)4127083-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Pharmakotherapie (DE-588)4076066-2 gnd Chemotherapeutikum (DE-588)4009895-3 gnd Arzneimittelwechselwirkung (DE-588)4003147-0 gnd Therapie (DE-588)4059798-2 gnd Pharmakokinetik (DE-588)4115557-9 gnd |
topic_facet | Zytostatika Cytostatikum Chemotherapie Krebs Medizin Pharmakotherapie Chemotherapeutikum Arzneimittelwechselwirkung Therapie Pharmakokinetik |
work_keys_str_mv | AT illigerhansj druginteractionsinthetherapyofmalignantdiseases AT herdrichklaus druginteractionsinthetherapyofmalignantdiseases AT illigerhansj arzneimittelinteraktionenbeidertherapiemalignererkrankungen AT herdrichklaus arzneimittelinteraktionenbeidertherapiemalignererkrankungen |